Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
ANUHPHR Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
Moderate revenue growth and above median growth of industry
Low Debt to Equity, not much change from last year
Consistently pays dividend
Company is net cash
Negative
Moderate ROE but declining trend
Low and declining operating margin
Low EPS growth and lower than median growth of industry
Neutral
Company's earnings are of moderate quality
Moderate dividend yield
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.207415.
Snapshot
See detailed analysis
ANUHPHR Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
ANUHPHR Bulk, Block & Insider Trades
ANUHPHR Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Bonus
Others
Bonus(1 new shares for 1 existing shares) Ex-date: 15th Jul 2025 Announced on: 23rd May 2025
Bonus(1 new shares for 1 existing shares) Ex-date: 18th Sep 2020 Announced on: 7th Aug 2020
Bonus(2 new shares for 1 existing shares) Ex-date: 5th Aug 2015 Announced on: 12th Jun 2015
Bonus(2 new shares for 1 existing shares)AGM 17 September 2010. BOD 08 October 2010. Ex-date: 28th Oct 2010 Announced on: 6th Aug 2010
Bonus(1 new shares for 1 existing shares)Bonus issue of 1:1. Ex-date: 3rd Sep 1999 Announced on: 3rd May 1999
Complex capital change1. Nominal value change from Rs. 10 to Rs. 5. 2. Bonus issue of 1 equity share for every 1 share held. Ex-date: 31st Jul 2006 Announced on: 29th Apr 2006
Company Profile
Anuh Pharma Limited is engaged in the business of manufacturing and selling bulk drugs and chemicals. The Companys products include active pharmaceutical ingredients and corticosteroids. Its active pharmaceutical ingredients include macrolides, anti-TB, anti-malarial, antibacterial, anti-hypertensio... Read More
Key personnel
Mr. Arun L. TodarwalD
Non-Executive Chairman of the Board
Shri. Bipin N. ShahD
Non-Executive Vice Chairman of the Board
Mr. Darshan Rampariya
Chief Financial Officer
Mr. Manan Jayesh Vadhan
Compliance Officer, Company Secretary
Mr. Ritesh Bipin ShahD
Joint Managing Director, Executive Director
Mr. Vivek Bipin ShahD
Joint Managing Director, Executive Director
Shri. Bharat N. ShahD
Non-Executive Non-Independent Director
Mr. Gaurav ShahD
Additional Non-Executive Non-Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Anuh Pharma Ltd.?
The current share price of Anuh Pharma Ltd. is ₹ 76.82 as of 09 Jan 2026.
What is the PE ratio of Anuh Pharma Ltd.?
The Price-to-Earnings (PE) ratio of Anuh Pharma Ltd. is 19.89 as of the latest financial data.
What is the ROE and ROCE of Anuh Pharma Ltd.?
Anuh Pharma Ltd. has a Return on Equity (ROE) of 12.29% and a Return on Capital Employed (ROCE) of 14.07% as per the latest financial reports.
What is the market cap of Anuh Pharma Ltd.?
The market capitalization of Anuh Pharma Ltd. stands at ₹ 769.92 Cr.
What is the dividend yield of Anuh Pharma Ltd.?
The dividend yield of Anuh Pharma Ltd. is 1.95% based on the current market price.
What is the RSI of Anuh Pharma Ltd.?
The Relative Strength Index (RSI) of Anuh Pharma Ltd. is 39.73.
What is the FII and DII holding in Anuh Pharma Ltd.?
Foreign Institutional Investors (FII) hold 0.00% and Domestic Institutional Investors (DII) hold 0.00% of Anuh Pharma Ltd. shares.
What sector does Anuh Pharma Ltd. belong to?
Anuh Pharma Ltd. operates in the Healthcare sector.
What is the beta of Anuh Pharma Ltd. stock?
The beta of Anuh Pharma Ltd. stock is 0.91, indicating its volatility relative to the broader market.
